A revolutionary technique that promises to restore the sight of millions has been carried out for the first time worldwide in a British hospital.
Taking as little as 45 minutes, the procedure offers hope to those with age-related macular degeneration, the leading cause of blindness in adults globally.
It affects more than 600,000 adults in the UK, blighting the lives of a quarter of the over-60s.
In the breakthrough developed at University College London, doctors inserted a patch of stem cells into the retina of a woman who has lost her central vision.
They hope the procedure, carried out at Moorfields Eye Hospital in the capital, will restore the 60-year-old’s sight but will not know the outcome until December.
However, doctors said she suffered no complications and her eye is recovering well from the procedure.
This first operation has begun a clinical trial involving ten patients. If successful, the technique could be available on the NHS within two-and-a-half years.
The procedure, which has attracted the support of medical giant Pfizer, is carried out under local anaesthetic. It involves taking a single embryonic stem cell and growing it into a 6mm patch of 100,000 retinal pigment cells.
That patch is then rolled into a thin tube, which is injected through a tiny slit in the eye.
Once unfurled, it is placed behind the retina where scientists hope it will replace the faulty cells.
The operation is a milestone in the London Project to Cure Blindness established ten years ago with the aim of curing vision loss in patients with age-related macular degeneration.
The first step has been carried out on the wet form of the condition when a patient bleeds at the back of the eye. But scientists are confident it could also be used for the more common dry AMD, which affects 85 per cent of British sufferers.
The Latest on: Age-related macular degeneration
[google_news title=”” keyword=”age-related macular degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Age-related macular degeneration
- Wet Age-Related Macular Degeneration Drug Pipeline Research Report 2023on November 28, 2023 at 4:33 am
The "Wet Age-Related Macular Degeneration - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Wet Age-related Macular Degeneration - Pipeline Insight, ...
- Researchers develop photoactivatable nanomedicine for the treatment of age-related macular degenerationon November 27, 2023 at 9:43 am
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), and collaborators from the Zhongshan Ophthalmic Center of Sun Yat-sen University, Guangzhou, have developed a ...
- New Treatment for Age-Related Macular Degenerationon November 26, 2023 at 4:01 pm
Neovascularization is responsible for severe vision loss in patients with age-related macular degeneration (AMD). A promising approach to this problem is to inhibit vascular endothelial growth ...
- Neovascular Age-Related Macular Degenerationon November 24, 2023 at 4:00 pm
Randomized, controlled clinical trials have demonstrated the value of laser photocoagulation and photodynamic therapy with verteporfin in selected patients with neovascular age-related macular ...
- What Is Wet Macular Degeneration?on November 17, 2023 at 4:00 pm
Worldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as “exudative ...
- Managing Age-Related Macular Degeneration (AMD) Vision Losson November 4, 2023 at 5:00 pm
Age-related macular degeneration (AMD) is the most common form of vision loss in adults over age 55 in developed countries. It is a condition that worsens over time. AMD affects the part of the retina ...
- Macular pigment and age related macular degenerationon September 27, 2023 at 1:00 pm
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
- Disease Focus: Age-related macular degenerationon July 12, 2023 at 9:22 pm
Age-related macular degeneration is a progressive disease resulting in death of the retinal pigment epithelium (RPE) causing distortion to central vision and eventually to legal blindness.
- Age-Related Macular Degenerationon June 30, 2023 at 10:51 am
Paulus T.V.M. de Jong, M.D., Ph.D. Figure 2. Figure 2. Progression from Early to Late Age-Related Macular Degeneration. Figure 3. Figure 3. RPE Cell in a 3-Year-Old Child (Left-Hand Panel ...
via Bing News